The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation

Chronic inflammatory diseases often affect women of childbearing age. Since biologic and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs) are more available, their use during conception, pregnancy and lactation has become a matter of concern. Current studies prove the...

Full description

Saved in:
Bibliographic Details
Published in:Postȩpy dermatologii i alergologii 2020-01, Vol.37 (3), p.306-312
Main Authors: Góralczyk, Alicja, Kolossa, Katarzyna, Waszczak-Jeka, Marzena, Adamczak, Rafał, Jeka, Sławomir
Format: Article
Language:English
Subjects:
Breastfeeding & lactation
Inflammatory diseases
Pregnancy
Review Paper
Tumor necrosis factor-TNF
Womens health
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c395t-bf1866db844a1bd35b8868f0d5baaa5ba709cf193059d75e4c2fedf259a4e1133
cites
container_end_page 312
container_issue 3
container_start_page 306
container_title Postȩpy dermatologii i alergologii
container_volume 37
creator Góralczyk, Alicja
Kolossa, Katarzyna
Waszczak-Jeka, Marzena
Adamczak, Rafał
Jeka, Sławomir
description Chronic inflammatory diseases often affect women of childbearing age. Since biologic and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs) are more available, their use during conception, pregnancy and lactation has become a matter of concern. Current studies prove the safety of innovative therapy in pregnant women and may contribute to its wider use than before in pregnancy and lactation. It mainly concerns tumour necrosis factor a (TNF-a) inhibitors. We searched PubMed using Medical Subject Headings (MeSH) terms and identified relevant studies and guidelines. We present up-to-date knowledge of bDMARDs and tsDMARDs safety in pregnant and breastfeeding women.
doi_str_mv 10.5114/ada.2020.96294
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7394167</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2432851343</sourcerecordid><originalsourceid>FETCH-LOGICAL-c395t-bf1866db844a1bd35b8868f0d5baaa5ba709cf193059d75e4c2fedf259a4e1133</originalsourceid><addsrcrecordid>eNpdkc1r3DAQxUVpaZY0154NvfTijb4sW5dCCf0IBHpJoTcxtsZeBVtyJbl0__tqd0OhnYMG9H483vAIecvovmFM3oKFPaec7rXiWr4gO861rimV6iXZMSV5LXTz44rcpPREyygmVKdfkyvB21ZyxndkfTxghb_XkLaIVQ5V78IcJjdU4G2VIU6Y0Vbp6PMBc_m2LiEkrJdg3Xh0fipgdvGA2wJnPW5Tqpyv1oiTBz8cz04zDLnowb8hr0aYE94872vy_fOnx7uv9cO3L_d3Hx_qoWTOdT-yTinbd1IC661o-q5T3Uht0wNAeVqqh5FpQRtt2wblwEe0I280SGRMiGvy4eK7bv2CdkCfI8xmjW6BeDQBnPlX8e5gpvDLtEJLptpi8P7ZIIafG6ZsFpcGnGfwGLZkuBS8ROo6XtB3_6FPYYu-nHehGibkKdH-Qg0xpBRx_BuGUXPq05Q-zalPc-5T_AEZ95Tl</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2432851343</pqid></control><display><type>article</type><title>The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation</title><source>PubMed Central (PMC)</source><source>Publicly Available Content (ProQuest)</source><creator>Góralczyk, Alicja ; Kolossa, Katarzyna ; Waszczak-Jeka, Marzena ; Adamczak, Rafał ; Jeka, Sławomir</creator><creatorcontrib>Góralczyk, Alicja ; Kolossa, Katarzyna ; Waszczak-Jeka, Marzena ; Adamczak, Rafał ; Jeka, Sławomir</creatorcontrib><description>Chronic inflammatory diseases often affect women of childbearing age. Since biologic and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs) are more available, their use during conception, pregnancy and lactation has become a matter of concern. Current studies prove the safety of innovative therapy in pregnant women and may contribute to its wider use than before in pregnancy and lactation. It mainly concerns tumour necrosis factor a (TNF-a) inhibitors. We searched PubMed using Medical Subject Headings (MeSH) terms and identified relevant studies and guidelines. We present up-to-date knowledge of bDMARDs and tsDMARDs safety in pregnant and breastfeeding women.</description><identifier>ISSN: 1642-395X</identifier><identifier>EISSN: 2299-0046</identifier><identifier>DOI: 10.5114/ada.2020.96294</identifier><identifier>PMID: 32774212</identifier><language>eng</language><publisher>Poznan: Termedia Publishing House</publisher><subject>Breastfeeding &amp; lactation ; Inflammatory diseases ; Pregnancy ; Review Paper ; Tumor necrosis factor-TNF ; Womens health</subject><ispartof>Postȩpy dermatologii i alergologii, 2020-01, Vol.37 (3), p.306-312</ispartof><rights>2020. This work is published under http://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright: © 2020 Termedia Sp. z o. o. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c395t-bf1866db844a1bd35b8868f0d5baaa5ba709cf193059d75e4c2fedf259a4e1133</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394167/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2432851343?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25730,27900,27901,36988,36989,44565,53765,53767</link.rule.ids></links><search><creatorcontrib>Góralczyk, Alicja</creatorcontrib><creatorcontrib>Kolossa, Katarzyna</creatorcontrib><creatorcontrib>Waszczak-Jeka, Marzena</creatorcontrib><creatorcontrib>Adamczak, Rafał</creatorcontrib><creatorcontrib>Jeka, Sławomir</creatorcontrib><title>The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation</title><title>Postȩpy dermatologii i alergologii</title><description>Chronic inflammatory diseases often affect women of childbearing age. Since biologic and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs) are more available, their use during conception, pregnancy and lactation has become a matter of concern. Current studies prove the safety of innovative therapy in pregnant women and may contribute to its wider use than before in pregnancy and lactation. It mainly concerns tumour necrosis factor a (TNF-a) inhibitors. We searched PubMed using Medical Subject Headings (MeSH) terms and identified relevant studies and guidelines. We present up-to-date knowledge of bDMARDs and tsDMARDs safety in pregnant and breastfeeding women.</description><subject>Breastfeeding &amp; lactation</subject><subject>Inflammatory diseases</subject><subject>Pregnancy</subject><subject>Review Paper</subject><subject>Tumor necrosis factor-TNF</subject><subject>Womens health</subject><issn>1642-395X</issn><issn>2299-0046</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkc1r3DAQxUVpaZY0154NvfTijb4sW5dCCf0IBHpJoTcxtsZeBVtyJbl0__tqd0OhnYMG9H483vAIecvovmFM3oKFPaec7rXiWr4gO861rimV6iXZMSV5LXTz44rcpPREyygmVKdfkyvB21ZyxndkfTxghb_XkLaIVQ5V78IcJjdU4G2VIU6Y0Vbp6PMBc_m2LiEkrJdg3Xh0fipgdvGA2wJnPW5Tqpyv1oiTBz8cz04zDLnowb8hr0aYE94872vy_fOnx7uv9cO3L_d3Hx_qoWTOdT-yTinbd1IC661o-q5T3Uht0wNAeVqqh5FpQRtt2wblwEe0I280SGRMiGvy4eK7bv2CdkCfI8xmjW6BeDQBnPlX8e5gpvDLtEJLptpi8P7ZIIafG6ZsFpcGnGfwGLZkuBS8ROo6XtB3_6FPYYu-nHehGibkKdH-Qg0xpBRx_BuGUXPq05Q-zalPc-5T_AEZ95Tl</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Góralczyk, Alicja</creator><creator>Kolossa, Katarzyna</creator><creator>Waszczak-Jeka, Marzena</creator><creator>Adamczak, Rafał</creator><creator>Jeka, Sławomir</creator><general>Termedia Publishing House</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BYOGL</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PKEHL</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200101</creationdate><title>The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation</title><author>Góralczyk, Alicja ; Kolossa, Katarzyna ; Waszczak-Jeka, Marzena ; Adamczak, Rafał ; Jeka, Sławomir</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c395t-bf1866db844a1bd35b8868f0d5baaa5ba709cf193059d75e4c2fedf259a4e1133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Breastfeeding &amp; lactation</topic><topic>Inflammatory diseases</topic><topic>Pregnancy</topic><topic>Review Paper</topic><topic>Tumor necrosis factor-TNF</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Góralczyk, Alicja</creatorcontrib><creatorcontrib>Kolossa, Katarzyna</creatorcontrib><creatorcontrib>Waszczak-Jeka, Marzena</creatorcontrib><creatorcontrib>Adamczak, Rafał</creatorcontrib><creatorcontrib>Jeka, Sławomir</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest East Europe, Central Europe Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Postȩpy dermatologii i alergologii</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Góralczyk, Alicja</au><au>Kolossa, Katarzyna</au><au>Waszczak-Jeka, Marzena</au><au>Adamczak, Rafał</au><au>Jeka, Sławomir</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation</atitle><jtitle>Postȩpy dermatologii i alergologii</jtitle><date>2020-01-01</date><risdate>2020</risdate><volume>37</volume><issue>3</issue><spage>306</spage><epage>312</epage><pages>306-312</pages><issn>1642-395X</issn><eissn>2299-0046</eissn><abstract>Chronic inflammatory diseases often affect women of childbearing age. Since biologic and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs) are more available, their use during conception, pregnancy and lactation has become a matter of concern. Current studies prove the safety of innovative therapy in pregnant women and may contribute to its wider use than before in pregnancy and lactation. It mainly concerns tumour necrosis factor a (TNF-a) inhibitors. We searched PubMed using Medical Subject Headings (MeSH) terms and identified relevant studies and guidelines. We present up-to-date knowledge of bDMARDs and tsDMARDs safety in pregnant and breastfeeding women.</abstract><cop>Poznan</cop><pub>Termedia Publishing House</pub><pmid>32774212</pmid><doi>10.5114/ada.2020.96294</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1642-395X
ispartof Postȩpy dermatologii i alergologii, 2020-01, Vol.37 (3), p.306-312
issn 1642-395X
2299-0046
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7394167
source PubMed Central (PMC); Publicly Available Content (ProQuest)
subjects Breastfeeding & lactation
Inflammatory diseases
Pregnancy
Review Paper
Tumor necrosis factor-TNF
Womens health
title The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T13%3A57%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20exposure%20to%20biologic%20and%20targeted%20synthetic%20disease-modifying%20antirheumatic%20drugs%20in%20pregnancy%20and%20lactation&rft.jtitle=Post%C8%A9py%20dermatologii%20i%20alergologii&rft.au=G%C3%B3ralczyk,%20Alicja&rft.date=2020-01-01&rft.volume=37&rft.issue=3&rft.spage=306&rft.epage=312&rft.pages=306-312&rft.issn=1642-395X&rft.eissn=2299-0046&rft_id=info:doi/10.5114/ada.2020.96294&rft_dat=%3Cproquest_pubme%3E2432851343%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c395t-bf1866db844a1bd35b8868f0d5baaa5ba709cf193059d75e4c2fedf259a4e1133%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2432851343&rft_id=info:pmid/32774212&rfr_iscdi=true